Clinical Trials Directory

Trials / Completed

CompletedNCT04377321

Colchicine Has Anti-diabetic Effect

Colchicine Has Anti-diabetic Effect and May be an Option for Type 2 Diabetes Management

Status
Completed
Phase
Study type
Observational
Enrollment
150 (actual)
Sponsor
Ministry of Health and Population, Egypt · Other Government
Sex
All
Age
35 Years – 55 Years
Healthy volunteers

Summary

Colchicine has antidiabetic effect and may be an option for type 2 diabetes management

Detailed description

Observational cohort prospective study with following of 150 newly diagnosed type 2 diabetes patients who were in 3 groups, had been monitored in a private clinic, each group 50 patients number, with 30 females and 20 males after written consent from all patients. The ages of all patients were between 35 and 55 years. The aim of this study was to evaluate colchicine effect on A1C of newly diagnosed type2 diabetes compared to the metformin and control group on diet only. The first group patients received colchicine 0.5twice daily for 6 months, the second group received metformin 1gm twice daily, the third group patients were on diet only. During the period of treatment, the investigators followed the patients if there were side effects of the drugs used. No side effects were monitored during the period of treatment except for gastric upset in some patients using metformin

Conditions

Interventions

TypeNameDescription
DRUGColchicine Tabletscolchicine tabletes for 6 months

Timeline

Start date
2019-10-10
Primary completion
2020-05-01
Completion
2020-05-02
First posted
2020-05-06
Last updated
2020-05-06

Locations

1 site across 1 country: Egypt

Regulatory

Source: ClinicalTrials.gov record NCT04377321. Inclusion in this directory is not an endorsement.